IRADIMED CORPORATION

NasdaqGM:IRMD 주식 보고서

시가총액: US$685.1m

IRADIMED 관리

관리 기준 확인 4/4

IRADIMED CEO는 Roger Susi, Jan2004 에 임명되었습니다 의 임기는 20.83 년입니다. 총 연간 보상은 $ 642.57K, 47.9% 로 구성됩니다. 47.9% 급여 및 52.1% 보너스(회사 주식 및 옵션 포함). 는 $ 248.02M 가치에 해당하는 회사 주식의 36.2% 직접 소유합니다. 248.02M. 경영진과 이사회의 평균 재임 기간은 각각 3.3 년과 8.4 년입니다.

주요 정보

Roger Susi

최고 경영자

US$642.6k

총 보상

CEO 급여 비율47.9%
CEO 임기20.8yrs
CEO 소유권36.2%
경영진 평균 재임 기간3.3yrs
이사회 평균 재임 기간8.4yrs

최근 관리 업데이트

Recent updates

IRADIMED's (NASDAQ:IRMD) Solid Profits Have Weak Fundamentals

Aug 08
IRADIMED's (NASDAQ:IRMD) Solid Profits Have Weak Fundamentals

If EPS Growth Is Important To You, IRadimed (NASDAQ:IRMD) Presents An Opportunity

Feb 23
If EPS Growth Is Important To You, IRadimed (NASDAQ:IRMD) Presents An Opportunity

Getting In Cheap On IRadimed Corporation (NASDAQ:IRMD) Is Unlikely

Feb 07
Getting In Cheap On IRadimed Corporation (NASDAQ:IRMD) Is Unlikely

Should You Investigate IRadimed Corporation (NASDAQ:IRMD) At US$45.06?

Nov 06
Should You Investigate IRadimed Corporation (NASDAQ:IRMD) At US$45.06?

Calculating The Intrinsic Value Of IRadimed Corporation (NASDAQ:IRMD)

Oct 13
Calculating The Intrinsic Value Of IRadimed Corporation (NASDAQ:IRMD)

At US$41.26, Is It Time To Put IRadimed Corporation (NASDAQ:IRMD) On Your Watch List?

Feb 05
At US$41.26, Is It Time To Put IRadimed Corporation (NASDAQ:IRMD) On Your Watch List?

Iradimed withdraws FDA filing for new infusion pump; prelim Q3 revenue rises 13% Y/Y

Oct 10

IRadimed: Record Revenue Could Translate To Share Price Appreciation

Aug 23

Here's Why We Think IRadimed (NASDAQ:IRMD) Is Well Worth Watching

Aug 17
Here's Why We Think IRadimed (NASDAQ:IRMD) Is Well Worth Watching

iRadimed Non-GAAP EPS of $0.26 beats by $0.02, revenue of $12.7M beats by $0.06M

Jul 29

IRadimed: Reduce Equity Beta With Upside Capture

Jul 18

IRadimed (NASDAQ:IRMD) Might Be Having Difficulty Using Its Capital Effectively

Jul 13
IRadimed (NASDAQ:IRMD) Might Be Having Difficulty Using Its Capital Effectively

At US$48.60, Is IRadimed Corporation (NASDAQ:IRMD) Worth Looking At Closely?

Feb 05
At US$48.60, Is IRadimed Corporation (NASDAQ:IRMD) Worth Looking At Closely?

Here's What's Concerning About IRadimed's (NASDAQ:IRMD) Returns On Capital

Jan 12
Here's What's Concerning About IRadimed's (NASDAQ:IRMD) Returns On Capital

CEO 보상 분석

Roger Susi 의 보수는 IRADIMED 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Sep 30 2024n/an/a

US$19m

Jun 30 2024n/an/a

US$19m

Mar 31 2024n/an/a

US$18m

Dec 31 2023US$643kUS$308k

US$17m

Sep 30 2023n/an/a

US$16m

Jun 30 2023n/an/a

US$15m

Mar 31 2023n/an/a

US$14m

Dec 31 2022US$586kUS$290k

US$13m

Sep 30 2022n/an/a

US$13m

Jun 30 2022n/an/a

US$12m

Mar 31 2022n/an/a

US$10m

Dec 31 2021US$615kUS$308k

US$9m

Sep 30 2021n/an/a

US$6m

Jun 30 2021n/an/a

US$5m

Mar 31 2021n/an/a

US$987k

Dec 31 2020US$435kUS$290k

US$1m

Sep 30 2020n/an/a

US$4m

Jun 30 2020n/an/a

US$5m

Mar 31 2020n/an/a

US$10m

Dec 31 2019US$488kUS$288k

US$10m

Sep 30 2019n/an/a

US$8m

Jun 30 2019n/an/a

US$8m

Mar 31 2019n/an/a

US$7m

Dec 31 2018US$495kUS$279k

US$6m

Sep 30 2018n/an/a

US$5m

Jun 30 2018n/an/a

US$3m

Mar 31 2018n/an/a

US$2m

Dec 31 2017US$474kUS$268k

US$500k

보상 대 시장: Roger 의 총 보상 ($USD 642.57K ) US 시장에서 비슷한 규모의 회사에 대한 평균보다 낮습니다( $USD 3.21M ).

보상과 수익: Roger 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Roger Susi (71 yo)

20.8yrs

테뉴어

US$642,566

보상

Mr. Roger E. Susi serves as President and Chief Executive Officer of IRadimed Corporation since May 28, 2020. He founded IRadimed Corporation in 2004 and has been its Chairman of the Board since June 10, 2...

리더십 팀

이름위치테뉴어보상소유권
Roger Susi
Founder20.8yrsUS$642.57k36.2%
$ 248.0m
John Glenn
CFO & Corporate Secretary2.4yrsUS$1.27m0.054%
$ 372.1k
Randy Waddell
Vice President of Worldwide Sales & Marketing3.3yrsUS$597.28k0.047%
$ 323.3k
Chris Williamson
Executive Vice President of Continuous Improvement & Information Technology2.4yrs데이터 없음데이터 없음
Matt Garner
Controller4.8yrs데이터 없음데이터 없음
Steve Kachelmeyer
Vice President of Regulatory Affairs & Quality Assuranceno dataUS$425.08k0.042%
$ 285.1k
Lynn Neuhardt
Vice President of Research & Developmentno dataUS$442.20k0.050%
$ 343.3k

3.3yrs

평균 재임 기간

경험이 풍부한 관리: IRMD 의 관리팀은 경험 ( 3.3 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름위치테뉴어보상소유권
Roger Susi
Founder8.4yrsUS$642.57k36.2%
$ 248.0m
James Hawkins
Director5.4yrsUS$159.36k0.31%
$ 2.1m
Anthony Vuoto
Independent Director8.7yrsUS$167.48k0.11%
$ 769.5k
Monty Allen
Independent Director10.8yrsUS$169.98k0.14%
$ 976.0k
Hilda Scharen-Guivel
Independent Director2.1yrsUS$153.11k0.028%
$ 191.0k

8.4yrs

평균 재임 기간

71yo

평균 연령

경험이 풍부한 이사회: IRMD 의 이사회는 경험(평균 재직 기간 8.4 년)으로 간주됩니다.